Matrine increases NKG2D ligand ULBP2 in K562 cells via inhibiting JAK/STAT3 pathway: a potential mechanism underlying the immunotherapy of matrine in leukemia.
about
Matrine increases NKG2D ligand ULBP2 in K562 cells via inhibiting JAK/STAT3 pathway: a potential mechanism underlying the immunotherapy of matrine in leukemia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Matrine increases NKG2D ligand ...... herapy of matrine in leukemia.
@ast
Matrine increases NKG2D ligand ...... herapy of matrine in leukemia.
@en
type
label
Matrine increases NKG2D ligand ...... herapy of matrine in leukemia.
@ast
Matrine increases NKG2D ligand ...... herapy of matrine in leukemia.
@en
prefLabel
Matrine increases NKG2D ligand ...... herapy of matrine in leukemia.
@ast
Matrine increases NKG2D ligand ...... herapy of matrine in leukemia.
@en
P2093
P2860
P1476
Matrine increases NKG2D ligand ...... herapy of matrine in leukemia.
@en
P2093
Jianyong Li
Lijia Jiang
Sixuan Qian
Xuzhang Lu
Zhichao Zhu
Zhuxia Jia
P2860
P304
P407
P577
2015-10-15T00:00:00Z